The ProCVT smart-sheet as a new screening tool for cardiovascular autonomic neuropathy: a feasibility study
The <i>ProCVT</i> smart-sheet offers a feasible, non-invasive alternative to traditional ECGs that rely on surface electrodes. CVT shows promise as a biomarker for identifying manifest CAN in T2D. However, long-term recordings of CVT were not superior to short-term recordings. Further research is warranted to assess its value in the detection of early-stage CAN.
Authors
- Maria Bitsch Poulsen (ORCID: https://orcid.org/0000-0001-5747-2584)
- Christina Brock (ORCID: https://orcid.org/0000-0002-3381-1884)
- Johan Røikjer (ORCID: https://orcid.org/0000-0002-4578-1328)
- Asbjørn Mohr Drewes (ORCID: https://orcid.org/0000-0001-7465-964X)
- Peter O.O. Julu (ORCID: https://orcid.org/0000-0001-7903-1990)
Institutions
- Steno Diabetes Centers (DK)
- Queen Mary University of London (GB)
- Aalborg University Hospital (DK)
- Steno Diabetes Center North Jutland (DK)
- William Harvey Research Institute (GB)
- Aalborg University (DK)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3389/fendo.2025.1653881
- Primary Topic
- Heart Rate Variability and Autonomic Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dexcom
- Spar Nord Fonden